Medifast, Inc. MED is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 17.60, higher than the ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Wellness company Medifast (NYSE:MED) reported Q3 CY2024 results exceeding the market’s revenue expectations, but sales fell ...

Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive ...

Fintel reports that on November 5, 2024, DA Davidson upgraded their outlook for Medifast (NYSE:MED) from Underperform to ...

Medifast ( (MED) ) has released its Q3 earnings. Here is a breakdown of the information Medifast presented to its investors. Medifast (NYSE: ...

For the current quarter ending in December, Medifast expects its per-share earnings to range from 10 cents to 65 cents. The company said it expects revenue in the range of $100 million to $120 million ...

DA Davidson analyst Linda Bolton Weiser upgraded Medifast (MED) to Neutral from Underperform with a price target of $17, up from $16.50. With ...

BALTIMORE (AP) — BALTIMORE (AP) — Medifast Inc. (MED) on Monday reported profit of $1.1 million in its third quarter. On a per-share basis, the Baltimore-based company said it had profit of 10 ...

Fintel reports that on November 5, 2024, DA Davidson upgraded their outlook for Medifast (NYSE:MED) from Underperform to Neutral. As of October 22, 2024, the average one-year price target for ...

With declining lithium prices leading to reduced 2025 operating costs and capex, here’s what we think of Albemarle stock. Maintaining independence and editorial freedom is essential to our ...